Clinical Trials for BCR-ABL1 Fusion Protein Expression

Find clinical trials for bcr-abl1 fusion protein expression. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Blinatumomab, Methotrexate, Cytarabine, and Ponatinib in Treating Patients With Philadelphia Chromosome-Positive, or BCR-ABL Positive, or Relapsed/Refractory, Acute Lymphoblastic Leukemia

NCT ID: NCT03263572

This clinical trial is studying a combination of four medications—blinatumomab, methotrexate, cytarabine, and ponatinib—to see how well they work for patients with Philadelphia chromosome-positive ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions